Abstract
Purpose
The goal of this study was to appraise the extent of unique content on disease-specific preference-based measures (DSPMs)
when contrasted with the EQ-5D using published studies and to inform whether EQ-5D could be inadequate as a utility measure
in its content coverage for a given disease-specific application.
when contrasted with the EQ-5D using published studies and to inform whether EQ-5D could be inadequate as a utility measure
in its content coverage for a given disease-specific application.
Results
Of 1,029 articles identified, 50 studies satisfied the inclusion criteria. The most frequent conditions where DSPMs were developed
included cancer (12 studies), coronary artery disease (4 studies), osteoarthritis, rheumatoid arthritis (3 studies of each),
obesity, and stroke (2 studies of each). Most studies involved mapping items or scores from disease-specific non-preference-based
measures onto a preference-based measure of health such as the EQ-5D. A substantial number of DSPMs appeared to include unique
content not covered by EQ-5D dimensions.
included cancer (12 studies), coronary artery disease (4 studies), osteoarthritis, rheumatoid arthritis (3 studies of each),
obesity, and stroke (2 studies of each). Most studies involved mapping items or scores from disease-specific non-preference-based
measures onto a preference-based measure of health such as the EQ-5D. A substantial number of DSPMs appeared to include unique
content not covered by EQ-5D dimensions.
Conclusions
Several conditions were identified as potential areas where the richness of the EQ-5D descriptive system could be enhanced.
It is yet unclear whether added dimension(s) would contribute unique explained variance to a utility score. Given the resources
required to rigorously develop a utility measure, the need for such measures should be carefully vetted.
It is yet unclear whether added dimension(s) would contribute unique explained variance to a utility score. Given the resources
required to rigorously develop a utility measure, the need for such measures should be carefully vetted.
- Content Type Journal Article
- Pages 1-22
- DOI 10.1007/s11136-012-0207-6
- Authors
- Fang-Ju Lin, Center for Pharmacoeconomic Research and Department of Pharmacy Practice and Pharmacy Administration, University of Illinois at Chicago, 833 South Wood St., Room 164, M/C 886, Chicago, IL 60612, USA
- Louise Longworth, Health Economics Research Group, Brunel University, London, UK
- A. Simon Pickard, Center for Pharmacoeconomic Research and Department of Pharmacy Practice and Pharmacy Administration, University of Illinois at Chicago, 833 South Wood St., Room 164, M/C 886, Chicago, IL 60612, USA
- Journal Quality of Life Research
- Online ISSN 1573-2649
- Print ISSN 0962-9343